SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-19-129493
Filing Date
2019-04-30
Accepted
2019-04-30 16:34:33
Documents
7
Effectiveness Date
2019-04-30

Document Format Files

Seq Description Document Type Size
1 DEFA14A d695277ddefa14a.htm DEFA14A 36737
2 GRAPHIC g695277g05e15.jpg GRAPHIC 23408
3 GRAPHIC g695277g16q56.jpg GRAPHIC 13701
4 GRAPHIC g695277g62d05.jpg GRAPHIC 24728
5 GRAPHIC g695277g76c99.jpg GRAPHIC 32714
6 GRAPHIC g695277g79o16.jpg GRAPHIC 31407
7 GRAPHIC g695277g87n84.jpg GRAPHIC 13084
  Complete submission text file 0001193125-19-129493.txt   229843
Mailing Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142 617-444-8550
Sesen Bio, Inc. (Filer) CIK: 0001485003 (see all company filings)

IRS No.: 262025616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36296 | Film No.: 19782341
SIC: 2834 Pharmaceutical Preparations